| Mrs Melanie Jean Koumentakos, PA C | |
|
113 Elm St, Suite 304, Enfield, CT 06082 | |
| (860) 741-2225 | |
| (860) 741-2229 |
| Full Name | Mrs Melanie Jean Koumentakos |
|---|---|
| Gender | Female |
| Speciality | Physician Assistant |
| Experience | 28 Years |
| Location | 113 Elm St, Enfield, Connecticut |
| Accepts Medicare Assignments | May be. She may accept the Medicare-approved amount; you may be billed for more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1295925956 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363A00000X | Physician Assistant | 001905 (Connecticut) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Baystate Medical Center | Springfield, MA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Hillside Dermatology Pc | 3971983073 | 6 |
News Archive
Indiana University Bloomington biologists who specialize in the ecology and evolution of microbes have been named one of 12 teams in the nation to receive funding from the National Science Foundation's Dimensions of Biodiversity Program.
Many of today's school teachers opt for dustless chalk to keep hands and classrooms clean. But according to a study published in the May issue of Annals of Allergy, Asthma & Immunology, the scientific journal of the American College of Allergy, Asthma and Immunology (ACAAI), this choice in chalk may cause allergy and asthma symptoms in students that have a milk allergy.
This bacterium, Escherichia coli K1, is the most common cause of meningitis in premature infants and the second most common cause of the disease in newborns. "The ineffectiveness of antibiotics in treating newborns with meningitis and the emergence of antibiotic-resistant strains of bacteria require new strategies," explains Nemani V. Prasadarao, PhD, associate professor of infectious disease at Childrens Hospital Los Angeles.
Janssen Pharmaceuticals, Inc. today announced that it has entered into a non-exclusive collaboration with Vertex Pharmaceuticals Incorporated to evaluate in a Phase 2 study the safety and efficacy of an all-oral regimen for the treatment of hepatitis C (HCV).
Scientists at the University of Liverpool and University of Utrecht have taken another step forward on their quest to develop a viable drug based on teixobactin - a new class of potent natural antibiotic capable of killing superbugs.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Melanie Jean Koumentakos, PA C 113 Elm St, Suite 304, Enfield, CT 06082 Ph: (860) 741-2225 | Mrs Melanie Jean Koumentakos, PA C 113 Elm St, Suite 304, Enfield, CT 06082 Ph: (860) 741-2225 |
News Archive
Indiana University Bloomington biologists who specialize in the ecology and evolution of microbes have been named one of 12 teams in the nation to receive funding from the National Science Foundation's Dimensions of Biodiversity Program.
Many of today's school teachers opt for dustless chalk to keep hands and classrooms clean. But according to a study published in the May issue of Annals of Allergy, Asthma & Immunology, the scientific journal of the American College of Allergy, Asthma and Immunology (ACAAI), this choice in chalk may cause allergy and asthma symptoms in students that have a milk allergy.
This bacterium, Escherichia coli K1, is the most common cause of meningitis in premature infants and the second most common cause of the disease in newborns. "The ineffectiveness of antibiotics in treating newborns with meningitis and the emergence of antibiotic-resistant strains of bacteria require new strategies," explains Nemani V. Prasadarao, PhD, associate professor of infectious disease at Childrens Hospital Los Angeles.
Janssen Pharmaceuticals, Inc. today announced that it has entered into a non-exclusive collaboration with Vertex Pharmaceuticals Incorporated to evaluate in a Phase 2 study the safety and efficacy of an all-oral regimen for the treatment of hepatitis C (HCV).
Scientists at the University of Liverpool and University of Utrecht have taken another step forward on their quest to develop a viable drug based on teixobactin - a new class of potent natural antibiotic capable of killing superbugs.
› Verified 4 days ago
Mrs. Melissa D'amato, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 140 Hazard Ave Ste 105, Enfield, CT 06082 Phone: 860-714-9733 Fax: 860-714-8136 | |
Mrs. Lori Ann Bryon, PA C Physician Assistant Medicare: Not Enrolled in Medicare Practice Location: 170 Hazard Ave, Enfield, CT 06082 Phone: 860-749-2022 | |
Madeline Murphy, PA Physician Assistant Medicare: Not Enrolled in Medicare Practice Location: 170 Hazard Ave, Enfield, CT 06082 Phone: 860-749-2022 Fax: 860-763-1398 | |
Mrs. Sarah Leigh Lasala, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 113 Elm St Ste 304, Enfield, CT 06082 Phone: 860-741-2225 Fax: 860-741-2229 | |
Julie M Wondolowski, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 701 Enfield St, Enfield, CT 06082 Phone: 860-741-6058 Fax: 860-741-6864 | |
Kaitlin G. Pulito, P.A.-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 701 Enfield Street, Enfield, CT 06082 Phone: 860-741-6058 Fax: 860-741-6864 |